1. Home
  2. NAMSW vs MRNOW Comparison

NAMSW vs MRNOW Comparison

Compare NAMSW & MRNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • MRNOW
  • Stock Information
  • Founded
  • NAMSW N/A
  • MRNOW N/A
  • Country
  • NAMSW Netherlands
  • MRNOW Mexico
  • Employees
  • NAMSW 29
  • MRNOW 556
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • MRNOW Blank Checks
  • Sector
  • NAMSW Health Care
  • MRNOW Finance
  • Exchange
  • NAMSW Nasdaq
  • MRNOW Nasdaq
  • Market Cap
  • NAMSW N/A
  • MRNOW N/A
  • IPO Year
  • NAMSW N/A
  • MRNOW N/A
  • Fundamental
  • Price
  • NAMSW $9.00
  • MRNOW $0.12
  • Analyst Decision
  • NAMSW
  • MRNOW
  • Analyst Count
  • NAMSW 0
  • MRNOW 0
  • Target Price
  • NAMSW N/A
  • MRNOW N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • MRNOW N/A
  • Earning Date
  • NAMSW N/A
  • MRNOW N/A
  • Dividend Yield
  • NAMSW N/A
  • MRNOW N/A
  • EPS Growth
  • NAMSW N/A
  • MRNOW N/A
  • EPS
  • NAMSW N/A
  • MRNOW N/A
  • Revenue
  • NAMSW N/A
  • MRNOW N/A
  • Revenue This Year
  • NAMSW N/A
  • MRNOW N/A
  • Revenue Next Year
  • NAMSW N/A
  • MRNOW N/A
  • P/E Ratio
  • NAMSW N/A
  • MRNOW N/A
  • Revenue Growth
  • NAMSW N/A
  • MRNOW N/A
  • 52 Week Low
  • NAMSW N/A
  • MRNOW N/A
  • 52 Week High
  • NAMSW N/A
  • MRNOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 47.49
  • MRNOW N/A
  • Support Level
  • NAMSW $9.40
  • MRNOW N/A
  • Resistance Level
  • NAMSW $10.14
  • MRNOW N/A
  • Average True Range (ATR)
  • NAMSW 0.44
  • MRNOW 0.00
  • MACD
  • NAMSW -0.12
  • MRNOW 0.00
  • Stochastic Oscillator
  • NAMSW 24.31
  • MRNOW 0.00

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About MRNOW Murano Global Investments PLC

Murano Global Investments PLC is a real estate company that owns, develops and invests in hotel, resort and commercial properties throughout Mexico. Its portfolio includes the Andaz and Mondrian Hotels in Mexico City, and Grand Island Cancun I, a 1,000+ room resort in Cancun, Mexico managed by the Hyatt Group. Murano also has an in-place pipeline of projects in Baja and Cancun.

Share on Social Networks: